Barclays’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Barclays’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-220,400	Closed	-$7.49M	–	7528
2014 Q4	$7.49M	Buy	220,400 +39,200	+22%	+$1.28M	0.01%	1384
2014 Q3	$5.25M	Buy	181,200 +124,700	+221%	+$2.64M	0.01%	1732
2014 Q2	$1.13M	Sell	56,500 -146,700	-72%	-$3.36M	﹤0.01%	3212
2014 Q1	$5.49M	Buy	203,200 +183,700	+942%	+$4.88M	0.01%	1627
2013 Q4	$390K	Sell	19,500 -11,000	-36%	-$207K	﹤0.01%	4345
2013 Q3	$549K	Sell	30,500 -24,200	-44%	-$437K	﹤0.01%	4011
2013 Q2	$909K	Buy	+54,700	New	+$874K	﹤0.01%	3499

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Barclays's AUXL Position: Q1 2015 in Review

Barclays sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 1,128,949 shares — an estimated $38.4M sold.

Barclays first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $65.4M in Q3 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Barclays reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Barclays sold 1,128,949 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $38.4M.
Barclays first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Barclays's AUXILIUM PHARAMCEUTICALS INC position peaked at $65.4M in Q3 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.